UK markets closed

Mydecine Innovations Group Inc. (MYCOF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0112+0.0001 (+0.90%)
At close: 09:30AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
7.493
0
7.493
2.617
Cost of revenue
-
0
0
0
Gross profit
-
0
7.493
2.617
Operating expenses
Research development
4,247
3,589
3,960
1,291
Selling general and administrative
15,692
9,821
13,819
7,360
Total operating expenses
20,168
16,389
22,692
11,462
Operating income or loss
-20,160
-16,389
-22,684
-11,459
Interest expense
742.445
911.594
205.267
182.866
Total other income/expenses net
-1,766
59.158
-693.508
-15,234
Income before tax
-22,669
-17,242
-23,583
-26,876
Income from continuing operations
-22,669
-17,242
-23,583
-26,876
Net income
-22,353
-11,567
-28,897
-26,949
Net income available to common shareholders
-22,353
-11,567
-28,897
-26,949
Basic EPS
-1.20
-1.34
-6.17
-12.05
Diluted EPS
-1.20
-1.34
-6.17
-12.05
Basic average shares
45,207
8,647
4,682
2,274
Diluted average shares
45,207
8,647
4,682
2,274